Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer

Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer is a phase 2, interventional study registered as NCT06718543 by fan li, with a registry enrolment figure of 100 participants, started 2025-02-10 and due to reach its primary completion in 2026-10-31. Interventions recorded: AK112 with SCRT and CapeOX; AK112 with SCRT. Conditions listed: Rectal Cancer. Primary outcome: Complete Response Rate. Colorectal eligibility wording from the registry: "Histologically confirmed rectal adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.